Spectrum: Local Antimicrobial Stewardship, for CHEO-OCTC

Acyclovir

C. diff Risk

NA

Oral Bioavailability

NA

Approximate Cost

NA

Spectrum Of Activity

General Spectrum of Activity

Spectrum Of Activity

Dosing

Pediatric

Neonatal

< 32 weeks GA

  • 40 mg/kg/day IV divided Q12H

> 32 weeks GA

  • 60 mg/kg/day IV divided Q8H

General Information

Drug Monitoring

Drug Monitoring

CBC and renal function recommended

First Line Indications

First Line Indications

Empiric and targeted therapy for Herpes simplex and varicella zoster virus infections